某妇幼保健院PDCA循环管理规范阿昔洛韦临床使用管理的成效分析及其策略

Analysis on Efficiency of Clinical Medication of Standardizing Aciclovir in a Hospital using PDCA Cycle Management and Its Strategy

目的:阿昔洛韦常被误用于常见病毒感染,探究运用PDCA循环管理规范阿昔洛韦的临床使用及其策略。方法:了解2018年临床使用阿昔洛韦的主要科室、医生及其疾病诊断数据;基于统计数据,2019年运用PDCA循环管理法制定相关"规范措施",尤其是搜集循证医学证据,邀请具有权威的感染病学专家宣教合理用药知识,规范阿昔洛韦的合理使用。结果:实施PDCA后每月监控并持续改进干预策略,阿昔洛韦用于常见病毒感染的用药处方显著减少,其处方合理率逐渐趋于100.00%。结论:PDCA管控模式成效显著、可行性强、针对性明确,阿昔洛韦不合理用药基本得到遏制。

Objective:To analyze aciclovir’s misuse in common viral infections,and to explore the clinical medication and strategies of aciclovir using PDCA cycle management.Methods:The major departments,doctors and disease diagnosis data of clinical usage of aciclovir in 2018 were investigated.Based on the statistical data,the PDCA cycle management method was used to formulate relevant"normative measures"in 2019,especially to collect evidence-based medical evidence,the authoritative infectious disease experts were invited to teach the knowledge of rational drug use and to regulate the rational usage of aciclovir.Results:After the implementation of PDCA,the monthly monitoring and continuous improvement of the intervention strategy resulted in a significant decrease in the prescription of aciclovir for common viral infections,and its prescription rationality rate gradually approached 100.00%.Conclusion:PDCA control model is effective,feasible and targeted,and the unreasonable usage of aciclovir is basically controlled.